Xencor | XNCR - Operating Expenses

Stock Price
8.41
Daily Change
-0.14 -1.64%
Monthly
20.14%
Yearly
-57.72%
Q3 Forecast
8.48

Xencor reported $76.78M in Operating Expenses for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 879.42M
Cash and Equivalent USD 44.44M
Cost of Sales USD 61.66M
Current Assets USD 513.15M
Current Liabilities USD 96.08M
Debt USD 67.93M
EBIT USD -22.83M
EBITDA USD -30.52M
Employees 250
EPS Earnings Per Share USD -0.41
Equity Capital and Reserves USD 620.35M
Gross Profit on Sales USD 43.61M
Interest Expense on Debt USD 8.24M
Interest Income USD 7.25M
Loan Capital USD 94.74M
Market Capitalization USD 522.6M
Net Income USD -30.83M
Operating Expenses USD 76.78M
Operating Profit USD -33.17M
Ordinary Share Capital USD 71.3M
PE Price to Earnings USD 29.92
Pre-Tax Profit USD -31.08M
Sales Revenues USD 43.61M
Selling and Administration Expenses USD 15.12M
Stock USD 0
Trade Creditors USD 18.53M
Trade Debtors USD 47.55M

Operating Expenses Change Date
AbbVie USD 9.71B 96M Jun/2025
Alnylam Pharmaceuticals USD 789.89M 213.78M Jun/2025
Amgen USD 6.52B 337M Jun/2025
Arrowhead Research USD 193.32M 31.81M Jun/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Cytokinetics USD 178.28M 21.06M Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
J&J USD 16.8B 8.54B Jun/2025
MacroGenics USD 59M 23.06M Jun/2025
Merck USD 9.44B 217M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
Regeneron Pharmaceuticals USD 2.6B 159.1M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Xencor USD 76.78M 865K Jun/2025